glp-1 gastroparesis law office in michigan semaglutide lawyer Gastroparesis Lawsuit michigan semaglutide digestive blockage lawsuit

Have more questions about Botox

Ozempic and the Risk of nAMD A recent article in JAMA Ophthamology (June 2025) suggests that vascular changes triggered by GLP-1 activity may trigger or worsen nAMD in some patients, especially those who are older, diabetic, or already at risk for macular degeneration

Brand-stated positioning, not a verified physiological claim

Once a patient reaches an effective, well-tolerated dose, treatment shifts into a maintenance phase, the same weekly dose continued over the following months, with periodic follow-ups and labs to confirm things are still on track

Should clinicians expect increased patient demand